Zalaris — Managed Services drive record performance

Zalaris (OSE: ZAL)

Last close As at 06/03/2026

NOK75.40

0.20 (0.27%)

Market capitalisation

NOK1,670m

More on this equity

Research: TMT

Zalaris — Managed Services drive record performance

Zalaris reported record FY25 revenue, with growth of 11.7% and an adjusted EBIT increase of 31.5% y-o-y (margin 12.9%). Managed Services (MS) continues to be the driver of growth and the business saw a pick-up in new business in Q425. Zalaris Consulting (ZC) performance was disappointing, with cost overruns in the APAC region contributing to a second loss-making quarter. Management continues to target double-digit revenue growth and margins of 13–15% and is increasingly embedding AI in its operations to improve productivity. Due to the weaker performance in ZC, we have taken a more conservative approach to our FY26 forecasts.

Katherine Thompson

Written by

Katherine Thompson

Director

Software and comp services

FY25 results

9 March 2026

Price NOK75.40
Market cap NOK1,665m

Net cash/(debt) at end FY25

NOK(216.7)m

Shares in issue

22.1m
Free float 65.6%
Code ZAL
Primary exchange OSLO
Secondary exchange N/A
Price Performance
% 1m 3m 12m
Abs (10.3) (16.6) (10.5)
52-week high/low NOK95.4 NOK64.5

Business description

Zalaris is a leading provider of comprehensive human capital management and payroll solutions.

Next events

Q126 results

28 April

Analyst

Katherine Thompson
+44 (0)20 3077 5700

Zalaris is a research client of Edison Investment Research Limited

Note: PBT and EPS (diluted) are normalised, excluding amortisation of acquired intangibles, exceptional items and share-based payments.

Year end Revenue (NOKm) PBT (NOKm) EPS (NOK) DPS (NOK) P/E (x) Yield (%)
12/24 1,346.3 80.7 2.70 0.90 27.9 1.2
12/25 1,503.2 123.5 3.90 2.50 19.3 3.3
12/26e 1,616.2 190.1 6.50 3.64 11.6 4.8
12/27e 1,747.5 217.4 7.38 4.30 10.2 5.7

Strong cash generation supports higher dividend

Zalaris reported Q425 revenue growth of 8.7% y-o-y, resulting in FY25 growth of 11.7% (MS +16.0%, ZC -0.7%). FY25 adjusted EBIT increased 31.5% y-o-y to generate a margin of 12.9% (MS 19.5%, ZC 3.2%). Year-end net debt excluding leases (which was refinanced in Q425) declined 12.5% to NOK217m with gearing at 0.8x. The company proposed a NOK2.5 dividend.

Medium-term goals intact; AI to drive efficiency

Management maintained its targets of annualised revenue of NOK2bn and EBIT margins of 13–15% by the end of FY28. After a slower period in H125, MS new business momentum is improving and the sales pipeline is strong. In ZC, measures have been taken to return the business to profitability. In conjunction with targeting average annual revenue growth of 10%, the company is using AI throughout the business to drive productivity improvements of 10% per year. Mainly reflecting weakness in ZC in H225, we trim our FY26 revenue by 0.5% and our adjusted operating profit by 4% (adjusted operating margin 13.4%). We introduce forecasts for FY27 for revenue growth of 8.1% and an adjusted EBIT margin of 13.7%.

Valuation: Medium-term goals support upside

On EV/sales multiples, Zalaris trades in line with IT services peers and, reflecting their higher structural profitability, at a discount to payroll software peers. On EV/EBIT and EV/EBITDA multiples it trades at a discount to both groups. We have rolled forward our discounted cash flow analysis by one year. Based on average revenue growth of 8.2% from FY25 to FY28 (and 4% thereafter) with a 13.7% adjusted operating margin, our discounted cash flow (DCF) analysis values the company at NOK108.1/share (down from NOK110.2/share), 43% above the current share price. Maintaining churn at low levels, winning new large multinational contracts and applying the optimum operating model in each region will be key to the company meeting, if not exceeding, these assumptions.

Review of FY25 results

Zalaris reported FY25 revenue growth 11.7% y-o-y (10.8% constant currency, cc). Growth was somewhat slower in Q425 at 8.7% (8.6% cc), mainly due to weakness in ZC (more detail in the divisional sections below). Revenue was marginally ahead of our forecast, with upside in MS more than offsetting downside in ZC.

FY25 adjusted EBIT, which was in line with our forecast, increased 31.5% resulting in an adjusted EBIT margin of 12.9%, up 1.9pp y-o-y. In Q425, adjusted EBIT increased 6.8% y-o-y generating a 12.8% margin, down 0.3pp y-o-y. Reported EBIT includes share-based payments of NOK13.4m, acquired intangibles amortisation of NOK14.9m and costs relating to the strategic review of NOK2.8m.

Net financial expense of NOK66.6m included a redemption premium of NOK19.1m paid when the bond was refinanced and was NOK11.7m higher than our forecast. Overall, normalised diluted EPS was 10.8% below our forecast due to higher net financial expenses and higher effective tax rate of 34.9% (our forecast 30.0%).

The company has proposed a dividend of NOK2.5. This equates to a payout ratio of 90% of basic reported EPS and 60% of PBT (Zalaris’s policy is to pay out at least 50% of PBT).

Zalaris generated operating cash flow of NOK162.5m (FY24: NOK131.5m), paid NOK15.1m for capex, NOK31.8m for leases and NOK19.6m for dividends. The bond refinancing in Q425 resulted in net repayment of borrowings and related fees of NOK78.8m. The company closed FY25 with net debt of NOK276.7m (-12.8% y-o-y) or NOK216.7m excluding leases (-12.5% y-o-y) and gearing reduced from 1.12x at the of FY24 and 0.89x at the end of Q325 to 0.76x at year-end.

Managed Services orders picking up

The MS business saw Q425 revenue growth of 15.4% y-o-y (14.9% cc), making up 80% of the quarter’s revenue. For FY25, revenue was 16.0% higher (14.7% cc). By geography, Germany saw 17% growth, Northern Europe 12% and UK and Ireland 48%. Net revenue retention in constant currency was 110% in Q425, reflecting a higher-than-normal level of change orders, which made up 17% of Q425 revenue versus 12% a year ago.

Adjusted EBIT increased 34.9% in FY25 and 13.7% in Q425, resulting in margins of 19.5% and 20.5%, respectively.

New business win momentum improved through the course of the year, with several multi-country deals signed including the first Irish-headquartered customer requiring EMEA coverage. In Q425, Zalaris won a major public sector deal in Norway, signing up the Norwegian Labour and Welfare Administration to provide payroll and HR solutions for more than 24,000 employees over a five-year period, extendable to up to 10 years. In total, the business signed new contracts worth annual recurring revenue (ARR) of NOK80m in Q425 and noted that it has a strong pipeline of deals that it expects to close in the next three months.

Zalaris is keen to expand its coverage to the entire G20, starting with full coverage of Europe. As part of this strategy, the company recently opened an office in the Netherlands to cover the Benelux region.

Exhibit 4 shows how Zalaris expects annualised revenue to develop based on MS contracts live and signed, assuming change orders at a rate of 12% of recurring revenue and ZC revenues at the same level as in FY25. Exhibit 5 shows the timing the company expects for signed contracts to go live. We note that this takes into account the churn from a top five customer (originally disclosed in Q324 results) where part of the service will be terminated from Q127.

Zalaris Consulting working towards break-even

The ZC business saw a Q425 revenue decline of 11.3% y-o-y (9.9% cc) and an FY25 revenue decline of 0.7% (0.5% cc). By geography, Q425 cc revenue was down 11.0% in Germany, 29.5% in Poland and 20.8% in the APAC region. Several factors combined to weigh on revenue, including reduced application management services work for a large customer in Poland and a significant amount of capacity being used to support MS implementation projects and change orders. The business has also found it harder to hire SuccessFactors consultants, particularly in Germany.

Adjusted EBIT declined to a loss of NOK1.3m in Q425 to generate a margin of -1.7%. For FY25, adjusted EBIT declined 48% to NOK10.9m with a margin of 3.2%. As well as the impact of lower revenues, in the APAC region, there were cost overruns on fixed price SuccessFactors projects that hit profitability in Q425. Management has taken corrective actions and expects a gradual normalisation of performance through Q126.

Moving to structured implementation of AI

Zalaris has moved from experimenting with AI tools to a structured implementation throughout the business. It is increasingly embedding AI within its operating model to improve scalability, enhance quality and support margin expansion. Through 2026–28, the company is targeting 10% annual productivity improvements, aiming to more than offset the costs of migrating to the SAP cloud. This will be achieved through a combination of digitisation, process standardisation and structured AI deployment across the delivery model. Management has also provided employees with access to AI tools and is encouraging daily use to boost productivity, supported by mandatory training and governance.

In MS, 15 key processes, some of which have already been digitised or partially automated, are under review for AI-enabled automation. The business is already using AI in sales support, software development and project execution. As an example of the potential benefits of AI, the business developed and delivered its MediExpense solution for a pharmaceutical client in less than three weeks.

Management sees significant opportunity in combining AI-enabled automation with its deep local payroll expertise. The company notes that, while payroll delivery will always require human oversight due to regulatory complexity and compliance requirements, AI can materially reduce manual processing, improve quality and enhance scalability. As payroll and HR outsourcing services are structured and repeatable, they are well suited to automation. Zalaris operates fully within GDPR and EU AI Act frameworks, and its European presence and regional delivery capabilities make it a good choice for companies concerned about data sovereignty.

As well as developing its own AI-enhanced processes, the company should be able to benefit from SAP’s investment in embedded AI within SuccessFactors and S/4HANA. Zalaris’ shared-services model means that AI investment is leveraged across its multi-customer base.

Outlook and changes to forecasts

The company reiterated its target to hit annual run-rate revenue of NOK2bn by Q428, with an adjusted EBIT margin of 13–15%. Each local region is targeting a margin of 15–20% before group costs. Management expects to be able to achieve a 10% average annual revenue growth after 1.5–3% annual churn and is targeting annual growth of 15% in MS. Through the use of AI across the business, management believes it is possible that margins could exceed the top end of the range by FY28.

We have revised our FY26 forecasts to temper group revenue growth, mainly due to weaker performance in ZC in H225. We have also trimmed our MS revenue growth rate, factoring in the progression of ARR expected by the company during the course of 2026. Lower revenue results in a 4% reduction in our adjusted operating profit forecast although the margin of 13.4% is still within the company’s target range. For FY27, we forecast revenue growth of 8.1% and the margin expanding to 13.7%. If we see sustained improvement from ZC and/or an increase in the number of large multi-country deals in MS, this could prove conservative. Our dividend per share forecasts are now calculated based on Zalaris’s policy of paying out 50% of PBT.

General disclaimer and copyright

This report has been commissioned by Zalaris and prepared and issued by Edison, in consideration of a fee payable by Zalaris. Edison Investment Research standard fees are £60,000 pa for the production and broad dissemination of a detailed note (Outlook) following by regular (typically quarterly) update notes. Fees are paid upfront in cash without recourse. Edison may seek additional fees for the provision of roadshows and related IR services for the client but does not get remunerated for any investment banking services. We never take payment in stock, options or warrants for any of our services.

Accuracy of content: All information used in the publication of this report has been compiled from publicly available sources that are believed to be reliable, however we do not guarantee the accuracy or completeness of this report and have not sought for this information to be independently verified. Opinions contained in this report represent those of the research department of Edison at the time of publication. Forward-looking information or statements in this report contain information that is based on assumptions, forecasts of future results, estimates of amounts not yet determinable, and therefore involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of their subject matter to be materially different from current expectations.

Exclusion of Liability: To the fullest extent allowed by law, Edison shall not be liable for any direct, indirect or consequential losses, loss of profits, damages, costs or expenses incurred or suffered by you arising out or in connection with the access to, use of or reliance on any information contained on this note.

No personalised advice: The information that we provide should not be construed in any manner whatsoever as, personalised advice. Also, the information provided by us should not be construed by any subscriber or prospective subscriber as Edison’s solicitation to effect, or attempt to effect, any transaction in a security. The securities described in the report may not be eligible for sale in all jurisdictions or to certain categories of investors.

Investment in securities mentioned: Edison has a restrictive policy relating to personal dealing and conflicts of interest. Edison Group does not conduct any investment business and, accordingly, does not itself hold any positions in the securities mentioned in this report. However, the respective directors, officers, employees and contractors of Edison may have a position in any or related securities mentioned in this report, subject to Edison's policies on personal dealing and conflicts of interest.

Copyright 2026 Edison Investment Research Limited (Edison).

Australia

Edison Investment Research Pty Ltd (Edison AU) is the Australian subsidiary of Edison. Edison AU is a Corporate Authorised Representative (1252501) of Crown Wealth Group Pty Ltd who holds an Australian Financial Services Licence (Number: 494274). This research is issued in Australia by Edison AU and any access to it, is intended only for "wholesale clients" within the meaning of the Corporations Act 2001 of Australia. Any advice given by Edison AU is general advice only and does not take into account your personal circumstances, needs or objectives. You should, before acting on this advice, consider the appropriateness of the advice, having regard to your objectives, financial situation and needs. If our advice relates to the acquisition, or possible acquisition, of a particular financial product you should read any relevant Product Disclosure Statement or like instrument.

New Zealand

The research in this document is intended for New Zealand resident professional financial advisers or brokers (for use in their roles as financial advisers or brokers) and habitual investors who are “wholesale clients” for the purpose of the Financial Advisers Act 2008 (FAA) (as described in sections 5(c) (1)(a), (b) and (c) of the FAA). This is not a solicitation or inducement to buy, sell, subscribe, or underwrite any securities mentioned or in the topic of this document. For the purpose of the FAA, the content of this report is of a general nature, is intended as a source of general information only and is not intended to constitute a recommendation or opinion in relation to acquiring or disposing (including refraining from acquiring or disposing) of securities. The distribution of this document is not a “personalised service” and, to the extent that it contains any financial advice, is intended only as a “class service” provided by Edison within the meaning of the FAA (i.e. without taking into account the particular financial situation or goals of any person). As such, it should not be relied upon in making an investment decision.

United Kingdom

This document is prepared and provided by Edison for information purposes only and should not be construed as an offer or sol icitation for investment in any securities mentioned or in the topic of this document. A marketing communication under FCA Rules, this document has not been prepared in accordance with the legal requirements designed to promote the independence of investment research and is not subject to any prohibition on dealing ahead of the dissemination of investment research.

This Communication is being distributed in the United Kingdom and is directed only at (i) persons having professional experience in matters relating to investments, i.e. investment professionals within the meaning of Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005, as amended (the "FPO") (ii) high net-worth companies, unincorporated associations or other bodies within the meaning of Article 49 of the FPO and (iii) persons to whom it is otherwise lawful to distribute it. The investment or investment activity to which this document relates is available only to such persons. It is not intended that this document be distributed or passed on, directly or indirectly, to any other class of persons and in any event and under no circumstances should persons of any other description rely on or act upon the contents of this document.

This Communication is being supplied to you solely for your information and may not be reproduced by, further distributed to or published in whole or in part by, any other person.

United States

Edison relies upon the "publishers' exclusion" from the definition of investment adviser under Section 202(a)(11) of the Investment Advisers Act of 1940 and corresponding state securities laws. This report is a bona fide publication of general and regular circulation offering impersonal investment-related advice, not tailored to a specific investment portfolio or the needs of current and/or prospective subscribers. As such, Edison does not offer or provide personal advice and the research provided is for informational purposes only. No mention of a particular security in this report constitutes a recommendation to buy, sell or hold that or any security, or that any particular security, portfolio of securities, transaction or investment strategy is suitable for any specific person.

London │ New York │ Frankfurt

20 Red Lion Street

London, WC1R 4PS

United Kingdom

More on Zalaris

View All

Latest from the TMT sector

View All TMT content

Research: Healthcare

Herantis Pharma — Momentum continues into FY26

Herantis Pharma’s FY25 results reflect positive momentum for HER-096, which is being developed as a potential disease-modifier for Parkinson’s disease (PD). Notably, the candidate successfully completed the Phase Ib trial, meeting primary and secondary endpoints. The associated biomarker programme also added to a robust foundation for Phase II, in our view. With a year-end gross cash position of €2.6m, plus a directed share issue of €4.2m (gross) in February 2026, Herantis has a cash runway into Q127 (according to management guidance). While this is not sufficient to execute the Phase II trial, it should cover the remaining preparations. Management is actively seeking partners to continue development activities, but is also exploring both equity and grant financing options.

Continue Reading